Dennis Wegener

Title: Dennis Wegener: Innovator in Virus-Like Particle Technology

Introduction

Dennis Wegener is a notable inventor based in Schenefeld, Germany. He has made significant contributions to the field of virology, particularly in the development of virus-like particles (VLPs). His innovative work focuses on enhancing the targeting capabilities of these particles for medical applications.

Latest Patents

Wegener holds a patent for the "Retargeting of viruses or VLPs." This invention relates to a method of producing a polyomavirus or polyomavirus-derived VLP that carries at least one targeting molecule on its surface. This targeting molecule is designed to bind to specific cells of interest. The patent also covers a composition that includes such a polyomavirus or polyomavirus-derived VLP, which can be utilized as a medicament. Additionally, the invention encompasses a kit that includes the polyomavirus or polyomavirus-derived VLP or the composition.

Career Highlights

Dennis Wegener is affiliated with the Deutsches Primatenzentrum GmbH Leibniz-Institut für Primatenforschung. His work at this institution has allowed him to explore innovative solutions in the field of primate research and virology. Wegener's research has the potential to impact therapeutic strategies significantly.

Collaborations

Wegener has collaborated with notable colleagues, including Arnd Steuernagel and Ellen Eckermann-Felkl. These collaborations have fostered a productive research environment, leading to advancements in their shared field of study.

Conclusion

Dennis Wegener's contributions to the development of virus-like particles demonstrate his commitment to advancing medical science. His innovative patent and collaborative efforts highlight the importance of targeted therapies in virology.